Alzheimer's Disease Clinical Trial
Official title:
Use of Autobiographical and Interest Assessment for a Better Stimulation of Patients in Nursing Home
The purpose is to evaluate patients' interests (patients in nursing home). Moreover the study aims to evaluate whether an activity for which the patient is interested in, allows a better involvement and stimulation.
Context :
Behavioral and Psychological Symptoms of Dementia (BPSD) arouse researchers' interest
because they are frequent manifestations responsible for a large share of the suffering of
patients and caregivers. Apathy is the most frequent of them.
Systematic literature reviews on non-pharmacological treatment for BPSD indicates that some
technique and more particularly residential care staff training program appear to have
promising results, even if the level of evidence of efficacy remains moderate partly because
of the paucity of scientific quality research in this area.
The most of them comes from Anglo-Saxon country. In France, the TNM en EHPAD study
demonstrated the staff training program efficacy regarding to the management of behavioral
positive symptoms such as agitation or aggressiveness compared to a control group
Aims of the study :
The aims of the study is to evaluate the short and medium term effectiveness of staff
training program to manage and stimulate patients with a diagnosis of Alzheimer's disease or
associated disorders and presenting BPSD of the apathy type and living in nursing homes.
Description :
A Randomized controlled trial (randomization by nursing home) presents as a routine clinical
procedure according to the French regulation. Raters and our statistician are unaware and
blind to the randomization. The trial takes place in 4 nursing homes.
To be included, patients are older than 65 years with a diagnosis of Alzheimer's disease or
associated disorder and present the diagnostic criteria of apathy, within a moderate to
severe stage of the disease.
Data are collected at baseline, month 1 and at month 4, namely 3 months after the end of the
training programme thanks to the Apathy Inventory Clinician version (AI-C), the
Neuropsychiatric Inventory for the staff members (NPI-ES), the AD QOL, an Observation Scale
and a qualitative analysis of the official caregiver's knowledge and perception about BPSD
especially apathy and their expectations concerning the training program.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05040048 -
Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
|
||
Withdrawn |
NCT03316898 -
A FDG-PET Study of AGN-242071 Added to Standard-of-Care (Donepezil ± Memantine) for the Treatment of Participants With Mild to Moderate Alzheimer's Disease
|
Phase 1 | |
Withdrawn |
NCT02860065 -
CPC-201 Alzheimer's Disease Type Dementia: PET Study
|
Phase 2 | |
Completed |
NCT01315639 -
New Biomarker for Alzheimer's Disease Diagnostic
|
N/A | |
Not yet recruiting |
NCT03740178 -
Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005)
|
Phase 1 | |
Recruiting |
NCT05607615 -
A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
|
Phase 2 | |
Terminated |
NCT03307993 -
Positron Emission Tomography (PET) Study in Patients With Alzheimer's Disease
|
Phase 1 | |
Recruiting |
NCT02912936 -
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
|
N/A | |
Active, not recruiting |
NCT02899091 -
Evaluation of the Safety and Potential Therapeutic Effects of CB-AC-02 in Patients With Alzheimer's Disease
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02868905 -
Identification of Epigenetic Markers Common to Obesity and Alzheimer's Disease in Women
|
N/A | |
Completed |
NCT02907567 -
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
|
Phase 1/Phase 2 | |
Terminated |
NCT02521558 -
Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease
|
N/A | |
Completed |
NCT02580305 -
SUVN-502 With Donepezil and Memantine for the Treatment of Moderate Alzheimer's Disease- Phase 2a Study
|
Phase 2 | |
Completed |
NCT02516046 -
18F-AV-1451 Autopsy Study
|
Phase 3 | |
Recruiting |
NCT02247180 -
Cognitive Rehabilitation in Alzheimer`s Disease
|
N/A | |
Completed |
NCT02260167 -
Treatment of Alzheimer's and Dementia With the Metabolism, Infections, Nutrition, Drug Elimination (MIND) Protocol
|
N/A | |
Terminated |
NCT02220738 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
|
Phase 1 | |
Completed |
NCT02317523 -
Alzheimer's Caregiver Coping: Mental and Physical Health
|
N/A | |
Completed |
NCT02256306 -
The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
|
N/A | |
Completed |
NCT02089555 -
African American Alzheimer's Progression Markers - CSF and Neuro-Imaging
|
N/A |